Home   >  
Angiogenesis/Protein Tyrosine Kinase
  >  
FAK

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products

Antibodies

Peptides

Catalysts

Impurities

Intermediate

Raw Materials

FAK

Chemical Structure Cat. No. Product Name CAS No.
Conteltinib Chemical Structure
 BCP48306 Conteltinib 1384860-29-0
Conteltinib is a tyrosine kinase inhibitor and an antineoplastic.
GSK215 Chemical Structure
 BCP46447 GSK215 2743427-26-9
GSK215 is a potent and selective PROTAC focal adhesion kinase (FAK) degrader.
AMP-945 Chemical Structure
 BCP45164 AMP-945 1393653-34-3
AMP945 is an inhibitor of the enzyme focal adhesion kinase (FAK) that plays a key role in the formation of scar tissue (fibrosis) both in cancer and diseases like IPF.
PF-562271 HCl Chemical Structure
 BCP42811 PF-562271 HCl 939791-41-0
PF-562271 is an orally bioavailable small molecule and ATP-competitive focal adhesion kinase (FAK) inhibitor with potential antineoplastic and antiangiogenic activities.
Y15 tetrahydrochloride Chemical Structure
 BCP27854 Y15 tetrahydrochloride 4506-66-5
Y15 is a potent and specific inhibitor of focal adhesion kinase (FAK) that inhibits its autophosphorylation activity, decreases the viability of cancer cells, and blocks tumor growth.
BI-4464 Chemical Structure
 BCP30859 BI-4464 1227948-02-8
BI-4464 is a highly selective ATP competitive inhibitor of PTK2/FAK, with an IC50 of 17 nM. A PTK2 ligand for PROTAC.
PF 4618433 Chemical Structure
 BCP29572 PF 4618433 1166393-85-6
PF 4618433 is an inhibitor of proline-rich tyrosine kinase 2 (PYK2) and focal adhesion kinase (FAK).
Y 11 Chemical Structure
 BCP28812 Y 11 1086639-59-9
Y11 is a small molecule inhibitor targeting Y397 site of FAK.
Repotrectinib Chemical Structure
 BCP19778 Repotrectinib 1802220-02-5
TPX-0005 is a potent ALK/ROS1/TRK inhibitor, with IC50 of 5.3 nM, 1.01 nM, 1.26 nM and 1.08 nM for SRC, WT ALK, ALK G1202R and ALK L1196M, respectively.
CEP-37440 Chemical Structure
 BCP13227 CEP-37440 1391712-60-9
CEP-37440 is a novel potent and selective Dual FAK/ALK inhibitor with IC50 s of 2.3 nM (FAK) and 120 nM(ALK cellular IC50 in 75% human plasma).
123下一页共 22 条记录 1 / 3 页 
0086-13720134139